Drug Interaction Report

Stiripentol and Dihydroergotamine Injection: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Dihydroergotamine Injection

DHE-45® Injection Migranal Trudhesa
+

Stiripentol

Diacomit Diacomit®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 13 documented Stiripentol interactions, 10 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia)

Interaction Deep Dive

Exert caution during the concomitant use of dihydroergotamine with moderate CYP3A4 inhibitors. Concomitant use may increase dihydroergotamine exposure which increases risk of vasospasm that may lead to cerebral ischemia and/or ischemia of the extremities4123.

Why it happens (mechanism)

Inhibition of CYP3A4-mediated metabolism of dihydroergotamine

Literature reports

1 report — tap to read

a) In a drug interaction study, coadministration of dihydroergotamine with itraconazole (CYP3A4 inhibitor) increased dihydroergotamine plasma exposure by 14% for Cmax and 19% for AUC while the plasma exposures (Cmax and AUC (0-inf)) of 8-beta-hydroxy dihydroergotamine (8-OH-DHE, active metabolite) were increased by approximately 4-fold and 3-fold, respectively 1.

Common questions

Can I take Stiripentol and Dihydroergotamine Injection together?

Increased dihydroergotamine exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Always confirm with your pharmacist or prescriber before making any change.

How serious is the Stiripentol and Dihydroergotamine Injection interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Stiripentol or Dihydroergotamine Injection need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (4)

  1. Product Information: ATZUMI(R) nasal powder, dihydroergotamine nasal powder. Satsuma Pharmaceuticals (per Manufacturer), Durham, NC, 2025. DailyMed
  2. Product Information: BREKIYA(R) subcutaneous injection, dihydroergotamine mesylate subcutaneous injection. Amneal Pharmaceuticals (Per Manufacturer), Bridgewater, NJ, 2025. DailyMed
  3. Product Information: TRUDHESA(TM) nasal spray, dihydroergotamine mesylate nasal spray. Impel NeuroPharma Inc (per DailyMed), Seattle, WA, 2021. DailyMed
  4. Product Information: Migranal(R) nasal spray, dihydroergotamine mesylate nasal spray. Bausch Health US LLC (per FDA), Bridgewater, NJ, 2022. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.